Skip to main content
logo
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.360
+0.140 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
4.510
+0.150 (3.44%)
After-hours: Mar 9, 2026, 7:35 PM EDT

Cytek Biosciences Revenue

In the year 2025, Cytek Biosciences had annual revenue of $201.49M with 0.52% growth. Cytek Biosciences had revenue of $62.14M in the quarter ending December 31, 2025, with 8.12% growth.

Revenue (ttm)
$201.49M
Revenue Growth
+0.52%
P/S Ratio
2.79
Revenue / Employee
$287,027
Employees
702
Market Cap
560.48M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025201.49M1.04M0.52%
Dec 31, 2024200.45M7.44M3.85%
Dec 31, 2023193.02M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 202092.84M34.96M60.39%
Dec 31, 201957.88M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Varex Imaging854.40M
Orthofix Medical822.31M
Avanos Medical701.20M
Bioventus568.09M
Tactile Systems Technology329.52M
OrthoPediatrics236.35M
SI-BONE200.93M
Beta Bionics100.25M
Revenue Rankings

CTKB News

More News